Risk factor
Negligible price volatility
Profitability factor
Very strong margins and returns
About
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation...
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers. Specifically, the stock is fairly valued on P/E, overvalued on EV/EBITDA, reasonab
Target Price
The average target price of RMD is 310 and suggests 20% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increase
Buy
Sell